University of Arizona researchers combined label-free multiphoton microscopy with neural networks to accurately classify pancreatic neuroendocrine neoplasms in tissue samples.
Key Details
- 1Multiphoton microscopy (MPM) was used to image pancreatic neuroendocrine neoplasm (PNEN) samples without labeling.
- 2Researchers trained both traditional machine learning and four convolutional neural networks (CNNs) on these images.
- 3CNNs achieved classification accuracies ranging from 90.8% to 96.4%, outperforming the ML algorithm’s 80.6%.
- 4Analysis showed key features included collagen content and image texture metrics.
- 5The approach is faster than traditional pathology and was validated across samples from multiple biorepositories.
- 6Publication: Biophotonics Discovery, October 2, 2025, DOI: 10.1117/1.BIOS.2.4.045001.
Why It Matters
This study demonstrates the potential of advanced imaging and AI for real-time, highly accurate tumor detection, which could transform intraoperative pathology and improve surgical outcomes in oncology. Faster, label-free diagnosis may reduce delays and error in tumor identification during surgery.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.